“We are very pleased to be working with this global, high growth health care company,” said J. Ladd Greeno, Chief Executive Officer of Quick-Med Technologies. “This collaboration is an important validation of the unique capabilities of our NIMBUS technology.”

The specific terms of the agreement were not disclosed.

About Quick-Med Technologies, Inc.

Quick-Med Technologies, Inc. (OTCBB:QMDT) is a life sciences company that is developing broad-based technologies for the healthcare and consumer markets. The Company's two core product groups under development are (1) NIMBUS^®, a technology employing advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer products; and (2) MultiStat™ family of advanced patented methods and compounds, shown to be effective in key skin care therapy applications for cosmetic, military, and medical markets. For more information, see: www.quickmedtech.com.

© 2008 Quick-Med Technologies, Inc. All rights reserved. NIMBUS^® and MultiStat™ are trademarks of Quick-Med Technologies, Inc. All other trademarks are the property of their respective owners.

Safe Harbor Forward-Looking Statements

Certain statements contained in this press release may be deemed to be forward-looking statements under federal securities laws, and Quick-Med Technologies, Inc. intends that such forward looking statements be subject to the safe harbor created thereby. Quick-Med Technologies, Inc. does not undertake an obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Quick-Med Technologies, Gainesville
Roy Carr, Director, Medical Devices Business Development
888-835-2211 Ext. 106
rcarr@quickmedtech.com